IPO stock Apogee eyed new highs Tuesday after its developmental inflammation treatment beat trial study objectives.
The post IPO Stock Apogee Rockets On Solid Phase 1 Outcome appeared first on Investor’s Business Daily.
IPO stock Apogee eyed new highs Tuesday after its developmental inflammation treatment beat trial study objectives.
The post IPO Stock Apogee Rockets On Solid Phase 1 Outcome appeared first on Investor’s Business Daily.